While the reduction in severe exacerbations did not reach statistical significance (HR: 0.676, 95% CI: 0.340–1.344), this may stem from heterogeneity in outcome definitions (e.g., hospitalization criteria) and limited statistical power due to event rarity.
← all excerpts
Effect of SGLT-2 inhibitors on COPD exacerbations in individuals with type 2 diabetes: A meta-analysis and Bayesian sensitivity analysis.
1
—
—